Antipsychotics Increase Risk for Metabolic Syndrome, CVD in Younger Patients - Psychiatry Advisor

Psychiatry AdvisorAntipsychotics Increase Risk for Metabolic Syndrome, CVD in Younger PatientsPsychiatry AdvisorNEW YORK — Pediatric and young adult patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk of developing metabolic syndrome and subsequent cardiovascular disease, according to research presented ...